First medication approved by FDA for patients with endogenous Cushing's syndrome

Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology

View the original article here